ADAM21
Disintegrin and metalloproteinase domain-containing protein 21
Also known as: ADA21_HUMAN, ADAM31
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UKJ8
- Gene
- ADAM21
- Ensembl
- ENSG00000139985
- Chromosome
- 14
- Canonical length
- 722 aa
- Protein class
- Predicted membrane proteins
OverviewNCBI Gene
This gene encodes a member of the ADAM (a disintegrin and metalloprotease domain) family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins, and have been implicated in a variety of biological processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. The expression of this gene expression is testis-specific. [provided by RefSeq, May 2011]
Canonical amino-acid sequenceUniProt
722 residues, UniProt reviewed canonical sequence.
>Q9UKJ8|ADAM21
1 MAVDGTLVYI RVTLLLLWLG VFLSISGYCQ AGPSQHFTSP EVVIPLKVIS RGRSAKAPGW
61 LSYSLRFGGQ KHVVHMRVKK LLVSRHLPVF TYTDDRALLE DQLFIPDDCY YHGYVEAAPE
121 SLVVFSACFG GFRGVLKISG LTYEIEPIRH SATFEHLVYK INSNETQFPA MRCGLTEKEV
181 ARQQLEFEEA ENSALEPKSA GDWWTHAWFL ELVVVVNHDF FIYSQSNISK VQEDVFLVVN
241 IVDSMYKQLG TYIILIGIEI WNQGNVFPMT SIEQVLNDFS QWKQISLSQL QHDAAHMFIK
301 NSLISILGLA YVAGICRPPI DCGVDNFQGD TWSLFANTVA HELGHTLGMQ HDEEFCFCGE
361 RGCIMNTFRV PAEKFTNCSY ADFMKTTLNQ GSCLHNPPRL GEIFMLKRCG NGVVEREEQC
421 DCGSVQQCEQ DACCLLNCTL RPGAACAFGL CCKDCKFMPS GELCRQEVNE CDLPEWCNGT
481 SHQCPEDRYV QDGIPCSDSA YCYQKRCNNH DQHCREIFGK DAKSASQNCY KEINSQGNRF
541 GHCGINGTTY LKCHISDVFC GRVQCENVRD IPLLQDHFTL QHTHINGVTC WGIDYHLRMN
601 ISDIGEVKDG TVCGPGKICI HKKCVSLSVL SHVCLPETCN MKGICNNKHH CHCGYGWSPP
661 YCQHRGYGGS IDSGPASAKR GVFLPLIVIP SLSVLTFLFT VGLLMYLRQC SGPKETKAHS
721 SGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ADAM21 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 8.1 nTPM
Expression across tissuesHPA
Tissue
- testis: 8.1 nTPM
- retina: 1.2 nTPM
- adrenal gland: 0.4 nTPM
- cerebellum: 0.4 nTPM
- cerebral cortex: 0.3 nTPM
- basal ganglia: 0.2 nTPM
Single-cell type
- late spermatids: 225 nCPM
- early spermatids: 96 nCPM
- adipocytes: 56 nCPM
- late primary spermatocytes: 53 nCPM
- cardiomyocytes: 35 nCPM
- myonuclei: 33 nCPM
Immune cell
- naive CD8 T-cell: 0.2 nTPM
- memory B-cell: 0.1 nTPM
- naive CD4 T-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- cerebral cortex: 5.8 nTPM
- basal ganglia: 4.6 nTPM
- hippocampal formation: 4.6 nTPM
- white matter: 4.6 nTPM
- amygdala: 4.4 nTPM
- choroid plexus: 4.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.43
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.31
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- EGF-like domain
- Peptidase M12B, ADAM/reprolysin
- Disintegrin domain
- Peptidase M12B, propeptide
- ADAM, cysteine-rich domain
- Disintegrin, conserved site
- Metallopeptidase, catalytic domain superfamily
- Reprolysin domain, adamalysin-type
- Disintegrin domain superfamily
- Disintegrin
- Reprolysin (M12B) family zinc metalloprotease
- Reprolysin family propeptide
- ADAM cysteine-rich
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ADAM21 as an antibody target. Whether an autoantibody or antibody against ADAM21 could matter depends on whether native ADAM21 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ADAM21 is annotated at the cell surface, where native ADAM21 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ADAM21 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...